Back

Participation rate in opportunistic screening compared to systematic screening for atrial fibrillation: STROKESTOP III

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and stroke Stroke in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Sofia Skroder

Orebro University, Orebro (Sweden)

6 More presentations in this session

Presentation thumbnail
The efficacy and safety of apixaban use in chronic liver disease: a secondary analysis of the ARISTOTLE trial
Doctor B. Suleiman (Durham, US)
Abstract Slides Video
Presentation thumbnail
A quantitative comparison of left- versus right-atrial intracardiac echocardiography for pulmonary vein visualization: a prospective single-center study
Doctor M. Pak (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Pharmacologic and non-pharmacologic interventions for preventing postoperative atrial fibrillation in cardiac surgery: systematic review and network meta-analysis
Doctor C. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Concurrent DOAC and rate control therapy in atrial fibrillation: nationwide time-dependent outcome analysis
Associate Professor R. Arbel (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Ablation efficacy and safety in elderly vs. super-elderly with atrial fibrillation: insights from the prospective multicenter REAL-AF registry
Doctor C. Dai (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and stroke

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical outcomes and costs in screening for AF.
3 April 2022
thumbnail
Congress Presentation
Opportunistic screening for atrial fibrillation and elevated/hypertensive blood pressure: clinical factors associated with abnormal findings
1 September 2025
thumbnail
Congress Presentation
Using the RE-AIM framework to evaluate the implementation of opportunistic atrial fibrillation screening in primary care.
12 April 2026
thumbnail
Congress Presentation
STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources